Ocular Therapeutixâ„¢ Announces Successful Topline Results from Phase 3 Clinical Trial of DEXTENZAâ„¢
Ocular Therapeutixâ„¢ Announces Presentation at the Ophthalmology Innovation Summit (OIS) at the American Society of Retina Specialists (ASRS)
Novaliq Announces Last Patient Enrolled in Phase 2 Clinical Trial of CyclASol® for the Treatment of Moderate to Severe Dry Eye Disease
Surface Metals Inc. Provides Corporate Update: Gold's 2025 Rally Amplifies Cimarron Gold Project Potential and Strengthens Strategic Position
Bold Ventures Provides Recent News at Koper Lake in the Ring of Fire and Burchell Gold and Copper Project